✦ LIBER ✦

Clinical and biochemical analysis of two families with type I and type II mannosidosis

✍ Scribed by Bennet, J. K. ;Dembure, P. P. ;Elsas, L. J.

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 609 KB
Volume: 55
Category: Article
ISSN: 0148-7299
DOI: 10.1002/ajmg.1320550108

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biochemical and genetic characterization

Biochemical and genetic characterization of type I familial amyloidotic polyneuropathy

✍ Dr. Masamitsu Nakazato; Hiroyuki Sasaki; Hirokazu Furuya; Yoshiyuki Sakaki; Teru 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB

Clinical and genetic analysis of 4 Mexic

Clinical and genetic analysis of 4 Mexican families with spinocerebellar ataxia type 10

✍ Astrid Rasmussen; Tohru Matsuura; Luis Ruano; Petra Yescas; Adriana Ochoa; Tetsu 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB 👁 2 views

Prenatal diagnosis and genetic analysis

Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia

✍ Chih-Ping Chen; Schu-Rern Chern; Jin-Chung Shih; Wayseen Wang; Li-Fan Yeh; Tung- 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 254 KB 👁 1 views

Spondyloepiphyseal dysplasia Maroteaux t

Spondyloepiphyseal dysplasia Maroteaux type: Report of three patients from two families and exclusion of type II collagen defects

✍ Nishimura, Gen ;Kizu, Rika ;Kijima, Yoshimaro ;Sakai, Kiyoshi ;Kawaguchi, Yoshih 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 178 KB

USH2A Mutation analysis in 70 Dutch fami

USH2A Mutation analysis in 70 Dutch families with Usher syndrome type II

✍ Ronald J.E. Pennings; Heleen te Brinke; Michael D. Weston; Annemarie Claassen; D 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 53 KB 👁 1 views

Usher syndrome type II (USH2) is characterised by moderate to severe high-frequency hearing impairment, progressive visual loss due to retinitis pigmentosa and intact vestibular responses. Three loci are known for USH2, however, only the gene for USH2a (USH2A) has been identified. Mutation analysis

Clinical pharmacokinetics of a placenta-

Clinical pharmacokinetics of a placenta-derived factor XIII concentrate in type I and type II factor XIII deficiency

✍ Dr. Francesco Rodeghiero; Alberto Tosetto; Eros Di Bona; Giancarlo Castaman 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 447 KB